Study of 18F-DCFPyL PET/CT, for Detection of Radiological Progression in Patients With Metastatic (M+) and Non-metastatic (M0) Castration Resistant Prostate Cancer Receiving Standard Androgen Receptor Targeted Treatment
Latest Information Update: 20 Dec 2021
At a glance
- Drugs Piflufolastat F18 (Primary)
- Indications Prostate cancer
- Focus Diagnostic use
Most Recent Events
- 14 Dec 2021 Status changed from recruiting to withdrawn prior to enrolment due to lack of funding.
- 10 Jul 2019 Planned initiation date changed from 1 Jun 2019 to 1 Aug 2019.
- 10 May 2019 Planned initiation date (Estimated date of firstparticipant enrollement) changed from 1 May 2019 to 1 Jun 2019.